PINK:BIOVF

Swedish Orphan Biovitrum AB (publ) Stock Insider Trading

Pink Sheets > Healthcare > Drug Manufacturers—Specialty & Generic

Open Broker Account

$25.76

+0 (+0%)

At Close: Jun 14, 2024

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About Swedish Orphan Biovitrum AB (publ)

Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. It offers Alprolix for haemophilia B; Doptelet treatment of thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic lymphohistiocytosis(HLH); Kineret for cryopyrin ... BIOVF Profile

Golden Star

Ticker	Date	Change	Price
LIN	Jun 12	0.640%	$434.17
BNDX	Jun 12	0.637%	$48.64
MAIN	Jun 12	0.673%	$49.01
EQR	Jun 11	1.77%	$65.55
RPM	Jun 11	0.92%	$110.28
FR	Jun 11	1.52%	$46.78
CAH	Jun 11	1.20%	$99.01
ESI	Jun 11	11.50%	$23.73
FTGC	Jun 11	0.374%	$24.09
FTSM	Jun 11	0.0838%	$59.68

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In

Swedish Orphan Biovitrum AB (publ) Stock Insider Trading

About Swedish Orphan Biovitrum AB (publ)

Golden Star

Top Fintech Company